198 related articles for article (PubMed ID: 34256698)
1. Individualized mobile health interventions for cardiovascular event prevention in patients with coronary heart disease: study protocol for the iCARE randomized controlled trial.
Chen Y; Ji M; Wu Y; Deng Y; Wu F; Lu Y
BMC Cardiovasc Disord; 2021 Jul; 21(1):340. PubMed ID: 34256698
[TBL] [Abstract][Full Text] [Related]
2. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
3. Effectiveness of eHealth cardiac rehabilitation on health outcomes of coronary heart disease patients: a randomized controlled trial protocol.
Su JJ; Yu DSF
BMC Cardiovasc Disord; 2019 Nov; 19(1):274. PubMed ID: 31783800
[TBL] [Abstract][Full Text] [Related]
4. Effects of Mobile Text Messaging on Glycemic Control in Patients With Coronary Heart Disease and Diabetes Mellitus: A Randomized Clinical Trial.
Huo X; Krumholz HM; Bai X; Spatz ES; Ding Q; Horak P; Zhao W; Gong Q; Zhang H; Yan X; Sun Y; Liu J; Wu X; Guan W; Wang X; Li J; Li X; Spertus JA; Masoudi FA; Zheng X
Circ Cardiovasc Qual Outcomes; 2019 Sep; 12(9):e005805. PubMed ID: 31474119
[TBL] [Abstract][Full Text] [Related]
5. Text4Heart II - improving medication adherence in people with heart disease: a study protocol for a randomized controlled trial.
Maddison R; Stewart R; Doughty R; Scott T; Kerr A; Benatar J; Whittaker R; Rawstorn JC; Rolleston A; Jiang Y; Estabrooks P; Sullivan RK; Bartley H; Pfaeffli Dale L
Trials; 2018 Jan; 19(1):70. PubMed ID: 29370829
[TBL] [Abstract][Full Text] [Related]
6. Effect of Text Messaging on Risk Factor Management in Patients With Coronary Heart Disease: The CHAT Randomized Clinical Trial.
Zheng X; Spatz ES; Bai X; Huo X; Ding Q; Horak P; Wu X; Guan W; Chow CK; Yan X; Sun Y; Wang X; Zhang H; Liu J; Li J; Li X; Spertus JA; Masoudi FA; Krumholz HM
Circ Cardiovasc Qual Outcomes; 2019 Apr; 12(4):e005616. PubMed ID: 30998400
[TBL] [Abstract][Full Text] [Related]
7. Improving coronary heart disease self-management using mobile technologies (Text4Heart): a randomised controlled trial protocol.
Dale LP; Whittaker R; Jiang Y; Stewart R; Rolleston A; Maddison R
Trials; 2014 Mar; 15():71. PubMed ID: 24588893
[TBL] [Abstract][Full Text] [Related]
8. An Intelligent Individualized Cardiovascular App for Risk Elimination (iCARE) for Individuals With Coronary Heart Disease: Development and Usability Testing Analysis.
Chen Y; Ji M; Wu Y; Wang Q; Deng Y; Liu Y; Wu F; Liu M; Guo Y; Fu Z; Zheng X
JMIR Mhealth Uhealth; 2021 Dec; 9(12):e26439. PubMed ID: 34898449
[TBL] [Abstract][Full Text] [Related]
9. Text Message and Internet Support for Coronary Heart Disease Self-Management: Results From the Text4Heart Randomized Controlled Trial.
Pfaeffli Dale L; Whittaker R; Jiang Y; Stewart R; Rolleston A; Maddison R
J Med Internet Res; 2015 Oct; 17(10):e237. PubMed ID: 26490012
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of team-based collaborative care for distressed patients in secondary prevention of chronic coronary heart disease (TEACH): study protocol of a multicenter randomized controlled trial.
Herrmann-Lingen C; Albus C; de Zwaan M; Geiser F; Heinemann K; Hellmich M; Michal M; Sadlonova M; Tostmann R; Wachter R; Herbeck Belnap B
BMC Cardiovasc Disord; 2020 Dec; 20(1):520. PubMed ID: 33302871
[TBL] [Abstract][Full Text] [Related]
11. Development of interventions for an intelligent and individualized mobile health care system to promote healthy diet and physical activity: using an intervention mapping framework.
Chen Y; Wu F; Wu Y; Li J; Yue P; Deng Y; Lamb KV; Fong S; Liu Y; Zhang Y
BMC Public Health; 2019 Oct; 19(1):1311. PubMed ID: 31623589
[TBL] [Abstract][Full Text] [Related]
12. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Machiyama K; Woodd S; Gubijev A; Barnard S; Russell S; Perel P; Free C
Cochrane Database Syst Rev; 2021 Mar; 3(3):CD012675. PubMed ID: 33769555
[TBL] [Abstract][Full Text] [Related]
13. mHealth Interventions for Lifestyle and Risk Factor Modification in Coronary Heart Disease: Randomized Controlled Trial.
Bae JW; Woo SI; Lee J; Park SD; Kwon SW; Choi SH; Yoon GS; Kim MS; Hwang SS; Lee WK
JMIR Mhealth Uhealth; 2021 Sep; 9(9):e29928. PubMed ID: 34559058
[TBL] [Abstract][Full Text] [Related]
14. Mobile phone-based interventions for improving adherence to medication prescribed for the primary prevention of cardiovascular disease in adults.
Palmer MJ; Barnard S; Perel P; Free C
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD012675. PubMed ID: 29932455
[TBL] [Abstract][Full Text] [Related]
15. Cardiovascular disease risk reduction in rural China: a clustered randomized controlled trial in Zhejiang.
Wei X; Zou G; Gong W; Yin J; Yu Y; Walley J; Zhang Z; King R; Chen K; Chong MK; Zee BC; Liu S; Tang J; Griffiths S; Yu M
Trials; 2013 Oct; 14():354. PubMed ID: 24160442
[TBL] [Abstract][Full Text] [Related]
16. Secondary prevention risk interventions via telemedicine and tailored patient education (SPRITE): a randomized trial to improve postmyocardial infarction management.
Shah BR; Adams M; Peterson ED; Powers B; Oddone EZ; Royal K; McCant F; Grambow SC; Lindquist J; Bosworth HB
Circ Cardiovasc Qual Outcomes; 2011 Mar; 4(2):235-42. PubMed ID: 21406672
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and safety of butylphthalide in secondary prevention of stroke: study protocol for a multicenter, real world trial based on Internet.
Lv J; Zhao D; Zhao G; Xie Z
BMC Neurol; 2022 Aug; 22(1):305. PubMed ID: 35986234
[TBL] [Abstract][Full Text] [Related]
18. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
[TBL] [Abstract][Full Text] [Related]
19. TEXT messages to improve MEDication adherence and Secondary prevention (TEXTMEDS) after acute coronary syndrome: a randomised clinical trial protocol.
Chow CK; Thiagalingam A; Santo K; Kok C; Thakkar J; Stepien S; Billot L; Jan S; Joshi R; Hillis GS; Brieger D; Chew DP; Rådholm K; Atherton JJ; Bhindi R; Collins N; Coverdale S; Hamilton-Craig C; Kangaharan N; Maiorana A; McGrady M; Shetty P; Thompson P; Rogers A; Redfern J
BMJ Open; 2018 Jan; 8(1):e019463. PubMed ID: 29374674
[TBL] [Abstract][Full Text] [Related]
20. A phase III wait-listed randomised controlled trial of novel targeted inter-professional clinical education intervention to improve cancer patients' reported pain outcomes (The Cancer Pain Assessment (CPAS) Trial): study protocol.
Phillips JL; Heneka N; Lovell M; Lam L; Davidson P; Boyle F; McCaffrey N; Fielding S; Shaw T
Trials; 2019 Jan; 20(1):62. PubMed ID: 30658657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
